These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 32085703)
1. Whole genome sequencing of Mycobacterium tuberculosis isolates and clinical outcomes of patients treated for multidrug-resistant tuberculosis in Tanzania. Katale BZ; Mbelele PM; Lema NA; Campino S; Mshana SE; Rweyemamu MM; Phelan JE; Keyyu JD; Majigo M; Mbugi EV; Dockrell HM; Clark TG; Matee MI; Mpagama S BMC Genomics; 2020 Feb; 21(1):174. PubMed ID: 32085703 [TBL] [Abstract][Full Text] [Related]
2. Transmission and Drug Resistance Genotype of Multidrug-Resistant or Rifampicin-Resistant Mycobacterium tuberculosis in Chongqing, China. Zhao B; Liu C; Fan J; Ma A; He W; Hu Y; Zhao Y Microbiol Spectr; 2022 Oct; 10(5):e0240521. PubMed ID: 36214695 [TBL] [Abstract][Full Text] [Related]
3. Whole genome sequencing analysis of Mycobacterium tuberculosis reveals circulating strain types and drug-resistance mutations in the Philippines. Wang L; Lim DR; Phelan JE; Reyes LT; Palparan AG; Sanchez MGC; Asuncion LAA; Tujan MAA; Medado IAP; Daga CMA; Llames JS; Mitarai S; Murase Y; Morishige Y; Ang CF; Malabad JCM; Montoya JC; Hafalla JC; Campino S; Hibberd ML; Ama CG; Basilio RP; La Paz EMC; Clark TG Sci Rep; 2024 Aug; 14(1):19602. PubMed ID: 39179783 [TBL] [Abstract][Full Text] [Related]
4. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone. Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924 [TBL] [Abstract][Full Text] [Related]
5. Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling. Elwenspoek MM; Thom H; Sheppard AL; Keeney E; O'Donnell R; Jackson J; Roadevin C; Dawson S; Lane D; Stubbs J; Everitt H; Watson JC; Hay AD; Gillett P; Robins G; Jones HE; Mallett S; Whiting PF Health Technol Assess; 2022 Oct; 26(44):1-310. PubMed ID: 36321689 [TBL] [Abstract][Full Text] [Related]
6. Machine learning-based prediction of antibiotic resistance in Mycobacterium tuberculosis clinical isolates from Uganda. Babirye SR; Nsubuga M; Mboowa G; Batte C; Galiwango R; Kateete DP BMC Infect Dis; 2024 Dec; 24(1):1391. PubMed ID: 39639222 [TBL] [Abstract][Full Text] [Related]
7. Diabetes as a risk factor for tuberculosis disease. Franco JV; Bongaerts B; Metzendorf MI; Risso A; Guo Y; Peña Silva L; Boeckmann M; Schlesinger S; Damen JA; Richter B; Baddeley A; Bastard M; Carlqvist A; Garcia-Casal MN; Hemmingsen B; Mavhunga F; Manne-Goehler J; Viney K Cochrane Database Syst Rev; 2024 Aug; 8(8):CD016013. PubMed ID: 39177079 [TBL] [Abstract][Full Text] [Related]
8. Collagenase injection versus limited fasciectomy surgery to treat Dupuytren's contracture in adult patients in the UK: DISC, a non-inferiority RCT and economic evaluation. Dias J; Tharmanathan P; Arundel C; Welch C; Wu Q; Leighton P; Armaou M; Corbacho B; Johnson N; James S; Cooke J; Bainbridge C; Craigen M; Warwick D; Brady S; Flett L; Jones J; Knowlson C; Watson M; Keding A; Hewitt C; Torgerson D Health Technol Assess; 2024 Dec; 28(78):1-262. PubMed ID: 39644138 [TBL] [Abstract][Full Text] [Related]
9. Characterization of pncA mutations in multi-drug and pyrazinamide resistant Mycobacterium tuberculosis isolates cultured from Queensland migrants and Papua New Guinea residents. Pandey S; Lavu E; Congdon J; Moke R; Bainomugisa A; Coulter C Tuberculosis (Edinb); 2018 Jul; 111():109-113. PubMed ID: 30029894 [TBL] [Abstract][Full Text] [Related]
10. Undernutrition as a risk factor for tuberculosis disease. Franco JV; Bongaerts B; Metzendorf MI; Risso A; Guo Y; Peña Silva L; Boeckmann M; Schlesinger S; Damen JA; Richter B; Baddeley A; Bastard M; Carlqvist A; Garcia-Casal MN; Hemmingsen B; Mavhunga F; Manne-Goehler J; Viney K Cochrane Database Syst Rev; 2024 Jun; 6(6):CD015890. PubMed ID: 38860538 [TBL] [Abstract][Full Text] [Related]
11. Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery. Bryant A; Hiu S; Kunonga PT; Gajjar K; Craig D; Vale L; Winter-Roach BA; Elattar A; Naik R Cochrane Database Syst Rev; 2022 Sep; 9(9):CD015048. PubMed ID: 36161421 [TBL] [Abstract][Full Text] [Related]
12. Frameshift mutations in the Snobre J; Meehan CJ; Mulders W; Rigouts L; Buyl R; de Jong BC; Van Rie A; Tzfadia O Antimicrob Agents Chemother; 2024 Dec; 68(12):e0085424. PubMed ID: 39445816 [TBL] [Abstract][Full Text] [Related]
13. Multi-level tuberculosis of the spine identified by 18 F-FDG-PET/CT and concomitant urogenital tuberculosis: a case report from the spinal TB X cohort. Scherer J; Mukasa SL; Wolmarans K; Guler R; Kotze T; Song T; Dunn R; Laubscher M; Pape HC; Held M; Thienemann F Infection; 2024 Dec; 52(6):2507-2519. PubMed ID: 38896371 [TBL] [Abstract][Full Text] [Related]
14. Harnessing Biological Insight to Accelerate Tuberculosis Drug Discovery. de Wet TJ; Warner DF; Mizrahi V Acc Chem Res; 2019 Aug; 52(8):2340-2348. PubMed ID: 31361123 [TBL] [Abstract][Full Text] [Related]
15. Long-term efficacy and safety of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): extended follow-up of an open-label, multicentre, randomised, non-inferiority trial. Goodall RL; Nunn AJ; Meredith SK; Bayissa A; Bhatnagar AK; Chiang CY; Conradie F; Gopalan N; Gurumurthy M; Kirenga B; Kiria N; Meressa D; Moodliar R; Ngubane N; Rassool M; Sanders K; Solanki R; Squire SB; Teferi M; Torrea G; Tsogt B; Tudor E; Van Deun A; Rusen ID; Lancet Respir Med; 2024 Dec; 12(12):975-987. PubMed ID: 39366400 [TBL] [Abstract][Full Text] [Related]
16. Opportunities and limitations of genomics for diagnosing bedaquiline-resistant tuberculosis: a systematic review and individual isolate meta-analysis. Nimmo C; Bionghi N; Cummings MJ; Perumal R; Hopson M; Al Jubaer S; Naidoo K; Wolf A; Mathema B; Larsen MH; O'Donnell M Lancet Microbe; 2024 Feb; 5(2):e164-e172. PubMed ID: 38215766 [TBL] [Abstract][Full Text] [Related]
17. Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model. Harnan S; Kearns B; Scope A; Schmitt L; Jankovic D; Hamilton J; Srivastava T; Hill H; Ku CC; Ren S; Rothery C; Bojke L; Sculpher M; Woods B Health Technol Assess; 2024 Oct; 28(73):1-230. PubMed ID: 39487661 [TBL] [Abstract][Full Text] [Related]
18. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs. Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602 [TBL] [Abstract][Full Text] [Related]
19. Xpert MTB/RIF assay in the diagnosis of pulmonary tuberculosis in children in tertiary care setting in South India. Velayutham B; Hissar S; Thiruvengadam K; Narayan Sivaramakrishnan G; Subramanyam B; Navaneethapandian P; Reddy D; Nair D; Kannabiran B; Balaji S; Selladurai E; Ganesh J; Aravind MA; Rathinam P; Chellaiah LR; Rose W; Luke Elizabeth H; Sakaya A; Joseph B; Sundaralingam V; Karthikeyan S; Dhanaraj B; Natrajan M; Swaminathan S J Trop Pediatr; 2024 Aug; 70(5):. PubMed ID: 39152039 [TBL] [Abstract][Full Text] [Related]